JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Park Aerospace
PKE
$720M
| $759K | ﹤0.01% |
39,627
+16,865
| +74% | +$360K |
|
|
KMG
3227
DELISTED
KMG Chemicals Inc
KMG
| $758K | ﹤0.01% |
29,775
+700
| +2% | +$20.5K |
|
|
EPZM
3228
DELISTED
Epizyme, Inc
EPZM
| $756K | ﹤0.01% |
31,475
-31,052
| -50% | -$598K |
|
3229
BlackRock Health Sciences Trust
BME
$569M
| $751K | ﹤0.01% |
+17,558
| New | +$754K |
|
|
CCXI
3230
DELISTED
ChemoCentryx, Inc.
CCXI
| $751K | ﹤0.01% |
91,222
-7,150
| -7% | -$56.8K |
|
3231
Perdoceo Education
PRDO
$2.17B
| $749K | ﹤0.01% |
227,068
-956,704
| -81% | -$4.04M |
|
3232
WD-40
WDFC
$2.98B
| $749K | ﹤0.01% |
8,598
+171
| +2% | +$14.5K |
|
3233
Invesco Water Resources ETF
PHO
$2.03B
| $748K | ﹤0.01% |
29,991
+1,283
| +4% | +$32.7K |
|
3234
Bank of Marin Bancorp
BMRC
$460M
| $747K | ﹤0.01% |
29,348
-52
| -0.2% | -$1.3K |
|
|
CEM
3235
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
| $747K | ﹤0.01% |
6,420
| – | – |
|
3236
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
| $742K | ﹤0.01% |
17,716
+1,211
| +7% | +$53.2K |
|
|
DEG
3237
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
| $742K | ﹤0.01% |
35,982
+10,933
| +44% | +$246K |
|
|
HGG
3238
DELISTED
hhgregg Inc.
HGG
| $741K | ﹤0.01% |
221,568
-1,777,444
| -89% | -$8.49M |
|
|
WRES
3239
DELISTED
WARREN RESOURCES INC
WRES
| $739K | ﹤0.01% |
1,607,212
-2,750,422
| -63% | -$2.36M |
|
3240
CALL
PepsiCo
PEP
$196B
| $737K | ﹤0.01% |
7,900
-5,700
| -42% | -$545K |
|
3241
Granite Construction
GVA
$5.16B
| $734K | ﹤0.01% |
20,694
+300
| +1% | +$10.9K |
|
|
BBT
3242
Beacon Financial Corp
BBT
$2.5B
| $733K | ﹤0.01% |
25,750
-360
| -1% | -$10.1K |
|
3243
Super Micro Computer
SMCI
$16.6B
| $729K | ﹤0.01% |
246,420
-1,405,200
| -85% | -$4.62M |
|
|
HTS
3244
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $728K | ﹤0.01% |
44,649
-4,583
| -9% | -$82.2K |
|
3245
Medifast
MED
$107M
| $727K | ﹤0.01% |
22,480
+650
| +3% | +$20.6K |
|
3246
Zevra Therapeutics
ZVRA
$578M
| $726K | ﹤0.01% |
+2,468
| New | +$538K |
|
|
TBNK
3247
DELISTED
Territorial Bancorp Inc.
TBNK
| $725K | ﹤0.01% |
29,855
+105
| +0.4% | +$2.45K |
|
3248
Invesco DB Agriculture Fund
DBA
$1.23B
| $721K | ﹤0.01% |
30,845
+4,449
| +17% | +$99.2K |
|
|
EPAY
3249
DELISTED
Bottomline Technologies Inc
EPAY
| $720K | ﹤0.01% |
+25,923
| New | +$715K |
|
3250
CALL
KB Home
KBH
$3.5B
| $717K | ﹤0.01% |
43,200
-766,400
| -95% | -$11.7M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.